A Pfizer and Cytel veteran on why statisticians belong at trial design, and why fewer sponsors keep them in-house.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
A New Take On The Evolving Role Of AI In Clinical Trials
Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.
-
Better eConsent Through Education Best Practices
eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.
-
Oncology Trials: Accuracy And Alleviating The Patient Screening Burden
Flatiron Health has unveiled an innovative service designed to enhance patient screening for clinical trials by integrating structured EHR data with machine learning and human analysis.
-
Clinical Data Like You've Never Seen It Before
In a recent webinar, experts from Revvity Signals Software explored how solutions like its Spotfire platform enable better, more streamlined clinical studies.
-
What's Driving Data Innovation: Notes From The Front Lines Of Change
Clinical data innovators prioritize risk-based quality management, standards, and closer collaboration with research sites. Many see AI as an important support rather than a top priority.
-
Harnessing The Power of Real-World Data In Clinical Trial Planning
As the availability of RWD grows, it creates opportunities for sponsors to use true patient insights to support their clinical strategy and bring treatments to patients in need.
-
Our Unified Platform Serves As eSource For COVID Treatment Trial
Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.
-
How eTMF Can Improve Global Clinical Trials
Without the right systems, global trial documentation adds risk. Centralized digital workflows improve visibility, audit readiness, and keep teams aligned, compliant, and efficient.
-
A Strategic Framework For Positive Site-Sponsor Relationships
Through an examination of evolving trial strategies and implementation, we aim to lay the groundwork for a collaborative, mutually beneficial atmosphere, ultimately leading to a sustainable competitive edge.
-
When Sites Don't Get Paid
Discover how Greenphire's innovative payment solutions can transform your clinical trial operations and ensure site sustainability.
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
RECENT NEWSLETTERS
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps